Evidence map›Paper›PMID 35165396›Full record

ArticleMolecular psychiatry2022

Regulation of sensorimotor gating via Disc1/Huntingtin-mediated Bdnf transport in the cortico-striatal circuit.

Hanna Jaaro-Peled, Sunil Kumar, Dalton Hughes, Akiko Sumitomo, Sun-Hong Kim, Sandra Zoubovsky, Yuki Hirota-Tsuyada, Diana Zala, Julie Bruyere, Brittany M Katz and 17 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Parvalbumin interneuron vulnerability and brain disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 11 institutions in 5 countries.

Hanna Jaaro-Peled *Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-8950-391X
Sunil Kumar *Department of Psychiatry and Behavioral Sciences, Neurobiology, and Biomedical Engineering, Duke University Medical Center, Durham, NC, USA.
Dalton HughesDepartment of Psychiatry and Behavioral Sciences, Neurobiology, and Biomedical Engineering, Duke University Medical Center, Durham, NC, USA.
Akiko SumitomoCentre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0003-3051-0485
Sun-Hong KimDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sandra ZoubovskyDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Yuki Hirota-TsuyadaMedical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Diana ZalaUniversity Grenoble Alpes, INSERM, U1216, CHU Grenoble Alpes, Grenoble Institut Neuroscience, 38000, Grenoble, France.ORCID http://orcid.org/0000-0002-0052-8011
Julie BruyereUniversity Grenoble Alpes, INSERM, U1216, CHU Grenoble Alpes, Grenoble Institut Neuroscience, 38000, Grenoble, France.
Brittany M KatzDepartment of Psychiatry and Behavioral Sciences, Neurobiology, and Biomedical Engineering, Duke University Medical Center, Durham, NC, USA.
Beverly HuangDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Rafael FloresDepartment of Neurosciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Soumya NarayanDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Zhipeng HouDepartment of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Aris N EconomidesRegeneron Pharmaceuticals, Tarrytown, NY, USA.
Takatoshi HikidaDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
William C WetselDepartment of Psychiatry and Behavioral Sciences, Neurobiology, and Biomedical Engineering, Duke University Medical Center, Durham, NC, USA.ORCID http://orcid.org/0000-0002-3592-7397
Karl DeisserothDepartments of Bioengineering and Psychiatry and Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-9440-3967
Susumu MoriDepartment of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Nicholas J BrandonJnana Therapeutics, Lexington, MA, USA.
Motomasa TanakaLaboratory for Protein Conformation Diseases, RIKEN Brain Science Institute, Wako, Japan.ORCID http://orcid.org/0000-0002-2994-7703
Koko IshizukaDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Miles D HouslayInstitute of Pharmaceutical Sciences, King's College London, London, UK.
Frédéric SaudouUniversity Grenoble Alpes, INSERM, U1216, CHU Grenoble Alpes, Grenoble Institut Neuroscience, 38000, Grenoble, France.ORCID http://orcid.org/0000-0001-6107-1046
Kafui DzirasaDepartment of Psychiatry and Behavioral Sciences, Neurobiology, and Biomedical Engineering, Duke University Medical Center, Durham, NC, USA. kafui.dzirasa@duke.edu.ORCID http://orcid.org/0000-0003-4280-9994
Akira SawaDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA. asawa1@jhmi.edu.ORCID http://orcid.org/0000-0003-1401-3008
Toshifumi TomodaCentre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, University of Toronto, Toronto, ON, Canada. toshifumi.tomoda@camh.ca.
Johns Hopkins University · USDuke University · USInserm · FRCentre for Addiction and Mental Health · CACity of Hope · USHoward Hughes Medical Institute · USJnana Therapeutics (United States) · USKing's College London · GBKyoto University · JPRegeneron (United States) · USRIKEN Center for Brain Science · JP

Funding

Project 3P50MH094268 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2011 to 2020
$19.9M
Akt/GSK-3 Signaling Cascade and the Actions of DopamineR37MH073853 · NIMH · DUKE UNIVERSITY · PI CARON, MARC G. · 2011 to 2020
$6.4M
Oxidative stress and schizophrenia: combination of cell biology and brain imagingR01MH092443 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2011 to 2015
$1.8M
Characterizing sensorimotor gaiting dysfunction in mouse models of schizophreniaR21MH099479 · NIMH · DUKE UNIVERSITY · PI DZIRASA, KAFUI · 2013 to 2014
$425k
NIMH NIH HHS P50 MH094268NIMH NIH HHS R01 MH092443NIMH NIH HHS R21 MH099479NIMH NIH HHS R37 MH073853
6 · The paper itself

Abstract

Sensorimotor information processing underlies normal cognitive and behavioral traits and has classically been evaluated through prepulse inhibition (PPI) of a startle reflex. PPI is a behavioral dimension deregulated in several neurological and psychiatric disorders, yet the mechanisms underlying the cross-diagnostic nature of PPI deficits across these conditions remain to be understood. To identify circuitry mechanisms for PPI, we performed circuitry recording over the prefrontal cortex and striatum, two brain regions previously implicated in PPI, using wild-type (WT) mice compared to Disc1-locus-impairment (LI) mice, a model representing neuropsychiatric conditions. We demonstrated that the corticostriatal projection regulates neurophysiological responses during the PPI testing in WT, whereas these circuitry responses were disrupted in Disc1-LI mice. Because our biochemical analyses revealed attenuated brain-derived neurotrophic factor (Bdnf) transport along the corticostriatal circuit in Disc1-LI mice, we investigated the potential role of Bdnf in this circuitry for regulation of PPI. Virus-mediated delivery of Bdnf into the striatum rescued PPI deficits in Disc1-LI mice. Pharmacologically augmenting Bdnf transport by chronic lithium administration, partly via phosphorylation of Huntingtin (Htt) serine-421 and its integration into the motor machinery, restored striatal Bdnf levels and rescued PPI deficits in Disc1-LI mice. Furthermore, reducing the cortical Bdnf expression negated this rescuing effect of lithium, confirming the key role of Bdnf in lithium-mediated PPI rescuing. Collectively, the data suggest that striatal Bdnf supply, collaboratively regulated by Htt and Disc1 along the corticostriatal circuit, is involved in sensorimotor gating, highlighting the utility of dimensional approach in investigating pathophysiological mechanisms across neuropsychiatric disorders.

Indexed as

Brain-Derived Neurotrophic FactorCorpus StriatumNerve Tissue ProteinsPrefrontal CortexPrepulse InhibitionAnimalsHumansMiceReflex, StartleSensory GatingBDNF protein, humanBdnf protein, mouseBrain-Derived Neurotrophic FactorDISC1 protein, humanDisc1 protein, mouseNerve Tissue Proteins

Identifiers

PMID35165396
PMCPMC9272458
OpenAlexW4213271923

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.